Cargando…

Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2

Mutations in leucine‐rich repeat kinase‐2 are the most common cause of familial Parkinson's disease. The prevalent G2019S mutation increase oxidative, kinase and toxic activity and inhibit endogenous peroxidases. We initially screened a library of 84 antioxidants and identified seven phenolic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angeles, Dario C., Ho, Patrick, Dymock, Brian W., Lim, Kah‐Leong, Zhou, Zhi‐Dong, Tan, Eng‐King
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818746/ https://www.ncbi.nlm.nih.gov/pubmed/27081659 http://dx.doi.org/10.1002/acn3.282

Ejemplares similares

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD)
por: Zhou, Zhi Dong, et al.
Publicado: (2016)

MAP1B rescues LRRK2 mutant-mediated cytotoxicity
por: Chan, Sharon L, et al.
Publicado: (2014)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
por: Liu, Wei, et al.
Publicado: (2022)

Deletion of the WD40 Domain of LRRK2 in Zebrafish Causes Parkinsonism-Like Loss of Neurons and Locomotive Defect
por: Sheng, Donglai, et al.
Publicado: (2010)

Non-Motor and Motor Features in LRRK2 Transgenic Mice
por: Bichler, Zoë, et al.
Publicado: (2013)

GTPase Activity and Neuronal Toxicity of Parkinson's Disease–Associated LRRK2 Is Regulated by ArfGAP1
por: Stafa, Klodjan, et al.
Publicado: (2012)

Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila
por: Chua, Ling Ling, et al.
Publicado: (2020)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population
por: Yu, Wen-Juan, et al.
Publicado: (2015)

A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson's Disease
por: Gómez-Suaga, Patricia, et al.
Publicado: (2012)

Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
por: Snead, David M., et al.
Publicado: (2022)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

Four-Year Longitudinal Study of Motor and Non-motor Symptoms in LRRK2-Related Parkinson's Disease
por: Deng, Xiao, et al.
Publicado: (2020)

Molecular Pathways Involved in LRRK2-Linked Parkinson’s Disease: A Systematic Review
por: Ravinther, Ailyn Irvita, et al.
Publicado: (2022)

Evaluating LRRK2 Genetic Variants with Unclear Pathogenicity
por: Refai, Fathima Shaffra, et al.
Publicado: (2015)

Identification of Targets from LRRK2 Rescue Phenotypes
por: Toh, Joanne, et al.
Publicado: (2021)

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
por: Gomes, Sara, et al.
Publicado: (2023)

Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
por: Kalogeropulou, Alexia F., et al.
Publicado: (2022)

LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations
por: Wu, Yih Ru, et al.
Publicado: (2012)

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Herrick, Mary K., et al.
Publicado: (2021)

Role of the ubiquitin proteasome system in Parkinson's disease
por: Lim, Kah-Leong, et al.
Publicado: (2007)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease
por: Hindle, Samantha J., et al.
Publicado: (2013)

LRRK2 Attenuates Antioxidant Response in Familial Parkinson’s Disease Derived Neural Stem Cells
por: Kim, Jeffrey, et al.
Publicado: (2023)

Patterns of Linkage Disequilibrium of LRRK2 across Different Races: Implications for Genetic Association Studies
por: Li, Huihua, et al.
Publicado: (2013)

Complete Genome Sequence of Serratia marcescens FY, Isolated from Drosophila melanogaster
por: Liu, Wei, et al.
Publicado: (2020)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
por: Lee, Heyne, et al.
Publicado: (2017)

α‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK2‐linked Parkinson's disease
por: Garrido, Alicia, et al.
Publicado: (2019)

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
por: Zhou, Zhi Dong, et al.
Publicado: (2022)

LRRK2 N551K and R1398H variants are protective in Malays and Chinese in Malaysia: A case–control association study for Parkinson's disease
por: Gopalai, Aroma Agape, et al.
Publicado: (2019)

Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence
por: Peeraully, Tasneem, et al.
Publicado: (2012)

LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1
por: Azkona, Garikoitz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gk4ip8r606iqno44dta3coctck